About Biomage
Biomage is a Healthcare company based in Glasgow (United Kingdom) founded in 2019, and was acquired by Parse Biosciences in January 2024. Provider of a cloud-based cell and genomic sequence analysis platform for researchers. Biomage has raised $1.51 million across 3 funding rounds from investors including Parse Biosciences and IndieBio. The company has 6 employees. Biomage was last valued at $3.91 thousand in April 2020. Its chief executive, as recorded, is Adam Kurkiewicz. Biomage offers products and services including Cellenics and scRNA-seq Course. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is BIOMAGE LTD.
Company details
Biomage was founded in 2019 and is based in Glasgow, United Kingdom. Operations focus on the biotechnology sector, where a cloud-based platform is offered for analyzing single-cell data. Tools are included for data integration, sequencing, bioimaging, and visualization. Graphical representations of cell distribution, cellular contents, and sequencing data are generated. Insights into analytical processes are supported for researchers in genomics and related fields.
- Headquarters Glasgow, United Kingdom
- Employees 6
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website biomage.net
- Social LinkedIn X
- Acquired by Parse Biosciences (Jan 2024)
- Legal Name Biomage Ltd
- Date of Incorporation 07 May, 2019
- Jurisdiction EDINBURGH, UNITED KINGDOM
- Total Equity Funding$1.51M (USD)
in 3 rounds
- Latest Funding Round$1.26M (USD), Seed
Jan 2021
- InvestorsParse Biosciences
& 1 more
- Employee Count6
- Acquired byParse Biosciences
(Jan 2024)
Products & Services of Biomage
Biomage offers a comprehensive portfolio of products and services, including Cellenics and scRNA-seq Course.
Open-source tool for exploring single-cell RNA-seq datasets without coding.
Online training for single-cell RNA sequencing data analysis techniques.
Funding Insights of Biomage
Biomage has successfully raised a total of $1.51M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.26 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.51M
- Total Rounds 3
- Last Round Seed — $1.26M
- Investors Count 1
All 3 funding rounds of Biomage with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $1.26M | Seed | – | – | – |
| Oct 2020 | $250,000 | Seed | – | IndieBio | – |
| Apr 2020 | Seed | $3,912 | – | – |
Last known valuation $3,912 (Apr 2020). 2 investors in total: 2 institutional.
Investors in Biomage
Biomage has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Parse Biosciences and IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States | ||
RNA-sequencing transcriptome kits for health data analysis are developed. | 2018 | parsebiosciences.com | Seattle, United States |
Investor details for Biomage
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biomage
6 people are tracked at Biomage (1 in leadership, 2 in board & advisors, 3 in team); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Adam Kurkiewicz | CEO | Leadership |
Peter Kharchenko | Scientific Co-Founder | Board & advisors |
Lomax Ward | Non Executive Director | Board & advisors |
Pol Alvarez Vecino | Principal Engineer | Team |
Sebastian Müller | Bioinformatics Consultant | Team |
Stefan Babukov | Junior Software Engineer | Team |
Complete people profiles for Biomage
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biomage
4 dated milestones of Biomage across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Biomage is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $1.3M.
- Exit Acquired by Parse Biosciences.
Web traffic of Biomage
The website of Biomage (biomage.net) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 11.4% vs previous month
Websites whose visitors overlap most with Biomage. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioturing.com | 100% | 18.3K | View details |
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Biomage (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biomage
Biomage was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Biomage is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Adam Kurkiewicz is the CEO of Biomage, as recorded in our data.
Biomage is a funded company, having raised a total of $1.51M across 3 funding rounds to date.
Biomage has 6 employees.
Biomage was founded in 2019 and is based in Glasgow, United Kingdom. Operations focus on the biotechnology sector, where a cloud-based platform is offered for analyzing single-cell data. Tools are included for data integration, sequencing, bioimaging, and visualization. Graphical representations of cell distribution, cellular contents, and sequencing data are generated. Insights into analytical processes are supported for researchers in genomics and related fields.
Biomage offers Cellenics and scRNA-seq Course.
Biomage has 2 investors. Key investors include Parse Biosciences, and IndieBio.
The valuation of Biomage is $3.91K as of Apr 2020.
Biomage operates through Biomage Ltd.
Yes. Biomage was acquired by Parse Biosciences in January 2024.